{"meta":{"query_hash":"fb63722942bf","filters":{"venue":"Kidney Cancer Journal"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fb63722942bf","api":"https://metacan.xera.ac/api/v1/cohort?venue=Kidney+Cancer+Journal"},"results":[{"id":"W3207058551","doi":"10.52733/kcj19n3-a1","title":"Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Duke Clinical Research Institute; National Cancer Institute; Cancer Research UK; National Institutes of Health; Pfizer","keywords":"Chromophobe cell; Sunitinib; Everolimus; Medicine; Renal cell carcinoma; Clinical endpoint; Biomarker; Clear cell; Oncology; Internal medicine; Clear cell renal cell carcinoma; Response Evaluation Criteria in Solid Tumors; Clinical trial; Pathology; Phases of clinical research; Biology","score_opus":0.05026666963239548,"score_gpt":0.36535789552615133,"score_spread":0.3150912258937558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207058551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97667783,0.0023834074,0.00069508626,0.012004104,0.0017417786,0.00059207756,0.000108475964,0.000013284547,0.0057839644],"genre_scores_gemma":[0.9917734,0.0004761865,0.0012564147,0.003630602,0.0013607901,0.000018732948,0.000110717425,0.00003157589,0.0013415766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719316,0.0006401519,0.00085089216,0.00041553803,0.00056737,0.0003328954],"domain_scores_gemma":[0.9976671,0.00063417776,0.00036201347,0.00045890367,0.00020339493,0.0006744446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088539533,0.00022400111,0.00073680753,0.00016876958,0.00012812897,0.00008336254,0.00019034145,0.00016436643,0.007081175],"category_scores_gemma":[0.0005593568,0.00014676487,0.0006099048,0.0009799105,0.00010546826,0.000075474716,0.000053296295,0.00090103416,0.000102561484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04266882,0.0012467856,0.8317033,0.000021110975,0.0075857593,0.0051748184,0.00089208793,0.00052312337,0.002686438,0.0000016003255,0.097270325,0.010225845],"study_design_scores_gemma":[0.14406964,0.00179302,0.7976833,0.0003973027,0.009537241,0.00006871475,0.0007909429,0.0042199614,0.014914054,0.000065181586,0.02604055,0.00042009502],"about_ca_topic_score_codex":0.0012739316,"about_ca_topic_score_gemma":0.00040255615,"teacher_disagreement_score":0.10140083,"about_ca_system_score_codex":0.00053658575,"about_ca_system_score_gemma":0.002319776,"threshold_uncertainty_score":0.9938265},"labels":[],"label_agreement":null},{"id":"W4220965877","doi":"10.52733/kcj20n1-gu2","title":"ASCO GU22 – Kidney Cancer Highlights","year":2022,"lang":"en","type":"article","venue":"Kidney Cancer Journal","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Kidney cancer; Cancer; Prostate cancer; Medicine; Genitourinary system; Renal cell carcinoma; Bladder cancer; Kidney; Oncology; Internal medicine; Gynecology","score_opus":0.02028934703914708,"score_gpt":0.3071120769885514,"score_spread":0.28682272994940433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220965877","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20906164,0.054133724,0.0004405609,0.5631772,0.04967294,0.0034917572,0.0066498187,0.00077675126,0.1125956],"genre_scores_gemma":[0.8009039,0.011086633,0.00068150315,0.11672831,0.009528727,0.0013065668,0.0001617401,0.00026279394,0.059339825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973163,0.00013070377,0.0004610124,0.00041628408,0.0010225824,0.0006531398],"domain_scores_gemma":[0.99737865,0.000018885243,0.0002463202,0.00035264879,0.00017900454,0.0018244913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025650603,0.00032483067,0.00050131965,0.00022847038,0.0009172831,0.00007598964,0.00030252853,0.00007383998,0.04247131],"category_scores_gemma":[0.000067978246,0.0002683831,0.00030093497,0.00043408488,0.00007049117,0.00018443706,0.00013103454,0.00095268217,0.000060480575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007189355,0.00034360882,0.028189942,0.000063781845,0.0008803623,0.0005438877,0.0010079903,0.000068336165,0.0037517897,0.00015843373,0.95442617,0.009846764],"study_design_scores_gemma":[0.0064889393,0.0005076224,0.007081742,0.00021073935,0.00058652356,0.0011917115,0.00013088687,0.00003847006,0.0038473767,0.0003156259,0.97927946,0.00032092482],"about_ca_topic_score_codex":0.0012817023,"about_ca_topic_score_gemma":0.00003445677,"teacher_disagreement_score":0.59184223,"about_ca_system_score_codex":0.0016744481,"about_ca_system_score_gemma":0.005376547,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4407003207","doi":"10.52733/kcj22n4-r1","title":"piRNAs and PIWI-Like Proteins in Renal Cell Carcinoma: A Systematic Review of Emerging Biomarkers and Potential Therapeutic Targets","year":2024,"lang":"en","type":"review","venue":"Kidney Cancer Journal","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Piwi-interacting RNA; Renal cell carcinoma; Biology; Cancer research; Medicine; Computational biology; Bioinformatics; Internal medicine; RNA; Genetics; RNA interference","score_opus":0.01711396828479383,"score_gpt":0.30631317145413695,"score_spread":0.2891992031693431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407003207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025720914,0.995501,0.000011368498,0.00074437266,0.0007466564,0.0026857746,0.00005367249,0.000014859743,0.00021657487],"genre_scores_gemma":[0.00041810353,0.9982033,0.00010664263,0.00039517347,0.00019746136,0.00014339774,0.00002567645,0.00008366255,0.0004265952],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964792,0.0004229295,0.0016951896,0.00045409997,0.0005190512,0.00042951884],"domain_scores_gemma":[0.9980176,0.000036895464,0.00096612406,0.0002745595,0.00012066222,0.0005841378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012498453,0.0005689473,0.0030634461,0.00067572546,0.000089419984,0.000057459565,0.0001677759,0.000361576,0.000115094634],"category_scores_gemma":[0.00010174511,0.00034174853,0.00060776423,0.00061486824,0.0001416304,0.0000744017,0.00009078194,0.0012405249,0.000004645456],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030279707,0.000045632027,0.000014643872,0.9724594,0.0012044365,0.0006708341,0.00015070348,3.3087172e-8,0.000066040135,0.0000014565275,0.0041479054,0.021208638],"study_design_scores_gemma":[0.0009971205,0.00016020138,0.0000114607055,0.90107775,0.020330796,0.0052790996,0.00006192665,0.000019361998,0.0000065556023,0.000012117753,0.07171472,0.00032890055],"about_ca_topic_score_codex":0.00005457459,"about_ca_topic_score_gemma":0.0000032553216,"teacher_disagreement_score":0.07138166,"about_ca_system_score_codex":0.0003313643,"about_ca_system_score_gemma":0.00189711,"threshold_uncertainty_score":0.99990344},"labels":[],"label_agreement":null}]}